MED30 protein was found to be widely overexpressed in cancerous tissue regions (Fig 1A–1D), and was obviously overexpressed in invading gastric cancer cells (Fig 1C) and in metastatic cancer cells inside affected lymph nodes (Fig 1D). Here, MED30 is linked to metastatic malignant neoplasm.